Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE2
Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)
- Status
- COMPLETED
- Phase
- PHASE2
Safety/Efficacy Study of Imprime PGG With Cetuximab in Patients With Recurrent/Progressive Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab in Multiple Phase I Combinations
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
- Status
- TERMINATED
- Phase
- PHASE2